Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Duncan, B.

Search results

  • RSS Feed
(1 - 4 of 4)
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population
Weinblatt, M.E.; Fleischmann, R.; Vollenhoven, R.F. van; Emery, P.; Huizinga, T.W.J.; Cutolo, M.; ... ; Dougados, M. 2015
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population
Article / Letter to editor
metadata only
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study
Weinblatt, M.E.; Fleischmann, R.; Huizinga, T.W.J.; Emery, P.; Pope, J.; Massarotti, E.M.; ... ; Dougados, M. 2012
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study
Article / Letter to editor
metadata only
CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ALIGNED WITH NICE GUIDANCE FOR ANTI-TNF THERAPY: POST-HOC ANALYSES OF THE REALISTIC PHASE IIIB RANDOMIZED CONTROLLED STUDY
Weinblatt, M.E.; Fleischmann, R.; Vollenhoven, R. van; Emery, P.; Huizinga, T.W.J.; Goldermann, R.; ... ; Dougados, M. 2012
CERTOLIZUMAB PEGOL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ALIGNED WITH NICE GUIDANCE FOR ANTI-TNF THERAPY: POST-HOC ANALYSES OF THE REALISTIC PHASE IIIB RANDOMIZED CONTROLLED STUDY
Article / Letter to editor
metadata only
Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study
Weinblatt, M.; Fleischmann, R.M.; Vollenhoven, R.F. van; Emery, P.; Huizinga, T.W.J.; Cutolo, M.; ... ; Dougados, M. 2011
Efficacy and Safety of Certolizumab Pegol in a Broad Population of Patients with Active Rheumatoid Arthritis: Week 28 Results From a Phase IIIb Randomized Controlled Study
Article / Letter to editor
metadata only